Oncology And Targeted Cancer Therapies Medication

Discover the exceptional quality of our Oncology And Targeted Cancer Therapies Medication, crafted by a trusted manufacturer, trader, and supplier with over 2 years of experience in the industry. Our comprehensive product line features must-have options such as Iclusig Ponatinib Tablets 45mg, Imanib Imatinib Tablets IP 400mg, Osimert Osimertinib Tablets 80mg, Iclusig Ponatinib Film-Coated Tablets 15mg, and Tagrisso Osimertinib Film-Coated Tablets 80mg, ensuring you get the ultimate solutions for advanced cancer treatment. These medications set the standard for targeted therapy, promising optimum efficacy, unmatched patient outcomes, and instant savings for healthcare providers. Uniquely formulated for the perfect balance of potency and safety, these therapeutics offer superior bioavailability, reduced side effects, and a focused approach to treating various oncology indications. Our products deliver five significant advantages:: cutting-edge molecular targeting, consistency in dosage accuracy, enhanced patient compliance, long shelf-life, and compatibility with diverse therapeutic regimens. Engineered for the modern healthcare landscape and available with a supply ability covering All India, these medications represent the best choice for oncologists seeking reliability and innovation in one package-choose our Oncology And Targeted Cancer Therapies Medication to experience the next level of care in cancer treatment.

Iclusig Ponatinib Film-Coated Tablets 15mg

Iclusig Ponatinib Film-Coated Tablets 15mg

MOQ : 50 Boxes

Dosage
As directed by physician, typically 15 mg once daily

Dosage Form
Tablet

Dosage Guidelines
Follow prescribed dosage schedule, do not exceed recommended dose

Drug Type
Other, Antineoplastic (anti-cancer) agent

Function
Other, Treatment of resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

Indication
Indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior tyrosine kinase inhibitor therapy

Ingredients
Ponatinib

Life Span
Refer to expiry date on packaging

Origin of Medicine
Pharmaceutical preparation

Pacakaging (Quantity Per Box)
30 Film-coated tablets

Packaging Type
Bottle in a box

Physical Form
Other, Film-coated tablet

Quantity
30 tablets per pack

Recommended For
Patients with certain types of leukemia and other cancers as prescribed by a physician

Salt Composition
Ponatinib hydrochloride

Storage Instructions
Store below 30C, in a dry place, protected from light

Suitable For
Adults

Osimert Osimertinib Tablets 80mg

Osimert Osimertinib Tablets 80mg

MOQ : 50 Strips

Dosage
80 mg once daily or as directed by physician

Dosage Form
Film-coated tablet

Dosage Guidelines
Follow physicians prescription strictly

Drug Type
Other, Prescription drug

Function
Other, Anticancer (EGFR Tyrosine Kinase Inhibitor)

Indication
Treatment of EGFR-positive non-small cell lung cancer

Ingredients
Osimertinib

Life Span
Refer to package for expiry date

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 tablets per box

Packaging Type
Box

Physical Form
Other, Tablet

Quantity
30 tablets per box

Recommended For
Patients with non-small cell lung cancer (NSCLC) with specific EGFR mutations

Salt Composition
Osimertinib 80 mg

Storage Instructions
Store below 30C, protect from moisture and light

Suitable For
Adults

Imanib Imatinib Tablets IP 400mg

Imanib Imatinib Tablets IP 400mg

MOQ : 50 Strips

Dosage
400 mg per tablet, as directed by physician

Dosage Form
Oral Tablet

Dosage Guidelines
Follow prescription or physicians instructions

Drug Type
Other, Allopathic

Function
Other, Anticancer, Tyrosine Kinase Inhibitor

Indication
Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST)

Ingredients
Imatinib Mesylate

Life Span
Refer to expiry on the pack, generally 24-36 months

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 Tablets or 100 Tablets per box, depending on packaging

Packaging Type
Box

Physical Form
Other, Tablet

Quantity
10 x 3 x 10 Tablets

Recommended For
Adults with chronic myeloid leukemia, gastrointestinal stromal tumors, and other specific cancers as prescribed

Salt Composition
Imatinib Mesylate

Storage Instructions
Store below 30C, protect from moisture and sunlight

Suitable For
Adults

Iclusig Ponatinib Tablets 45mg

Iclusig Ponatinib Tablets 45mg

MOQ : 50 Strips

Dosage
45 mg per tablet, as directed by healthcare provider

Dosage Form
Oral tablet

Dosage Guidelines
Swallow the tablets whole. Do not cut, crush, or dissolve the tablets. Follow physicians prescription

Drug Type
Other, Prescription only (Rx)

Function
Other, Tyrosine kinase inhibitor for cancer treatment

Indication
Indicated for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)

Ingredients
Ponatinib

Life Span
See packaging for expiry date

Origin of Medicine
Manufactured by Takeda Pharmaceuticals

Pacakaging (Quantity Per Box)
30 tablets

Packaging Type
Box

Physical Form
Other, Tablet

Quantity
30 tablets per box

Recommended For
Prescribed for patients with certain types of leukemia (CML and ALL)

Salt Composition
Ponatinib hydrochloride

Storage Instructions
Store at room temperature, keep in original packaging, away from moisture and heat

Suitable For
Other, Adults, as prescribed

Tagrisso Osimertinib Film-Coated Tablets 80mg

Tagrisso Osimertinib Film-Coated Tablets 80mg

MOQ : 50 Boxes

Dosage
80 mg once daily or as directed by a physician

Dosage Form
Film-coated tablet

Dosage Guidelines
Take orally, with or without food

Drug Type
Other, Antineoplastic agent

Function
Other, Targeted therapy for treatment of EGFR-mutated NSCLC

Indication
Treatment of metastatic or locally advanced non-small cell lung cancer (NSCLC) with EGFR T790M mutation

Ingredients
Osimertinib

Life Span
Refer to expiry date on packaging (typically 2-3 years from manufacture)

Origin of Medicine
Pharmaceutical

Pacakaging (Quantity Per Box)
30 tablets per box

Packaging Type
Box with blister strips

Physical Form
Other, Film-coated tablet

Quantity
30 tablets per box

Recommended For
Patients with non-small cell lung cancer (NSCLC) with specific EGFR mutations

Salt Composition
Osimertinib (as mesylate)

Storage Instructions
Store below 30C, in the original package to protect from moisture

Suitable For
Adults

✕